<?xml version="1.0" encoding="UTF-8"?><?xml-model type="application/xml-dtd" href="https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1-3.dtd"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "https://jats.nlm.nih.gov/publishing/1.3/JATS-journalpublishing1-3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" specific-use="Marcalyc 1.3" dtd-version="1.3" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="index">5704</journal-id>
<journal-title-group>
<journal-title specific-use="original" xml:lang="pt">Revista de Epidemiologia e Controle de Infecção</journal-title>
<abbrev-journal-title abbrev-type="publisher" xml:lang="pt">RECI</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2238-3360</issn>
<publisher>
<publisher-name>Universidade de Santa Cruz do Sul</publisher-name>
<publisher-loc>
<country>Brasil</country>
<email>liapossuelo@unisc.br</email>
</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="art-access-id" specific-use="redalyc">570481700001</article-id>
<article-id pub-id-type="doi">10.17058/reci.v15i1.19391</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Artigo Original</subject>
</subj-group>
</article-categories>
<title-group>
<article-title xml:lang="en">Nurses’ knowledge about safety in the clinical management of patients with influenza: a cross-sectional study</article-title>
<trans-title-group>
<trans-title xml:lang="pt">Conhecimento de enfermeiros sobre a segurança no manejo clínico de pacientes com influenza: estudo transversal</trans-title>
</trans-title-group>
<trans-title-group>
<trans-title xml:lang="es">Conocimientos del enfermero sobre seguridad en el manejo clínico de pacientes con influenza: estudio transversal</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="no">
<name name-style="western">
<surname>Guimarães Gomes Campos</surname>
<given-names>Regina Kelly</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
<email>reginakellyguimaraesgomes@gmail.com</email>
</contrib>
<contrib contrib-type="author" corresp="no">
<name name-style="western">
<surname>Barreira Pinheiro</surname>
<given-names>Angélica</given-names>
</name>
<xref ref-type="aff" rid="aff2"/>
</contrib>
<contrib contrib-type="author" corresp="no">
<name name-style="western">
<surname>Costa de Freitas Maniva</surname>
<given-names>Samia Jardelle</given-names>
</name>
<xref ref-type="aff" rid="aff3"/>
</contrib>
<contrib contrib-type="author" corresp="no">
<name name-style="western">
<surname>Lima Benevides</surname>
<given-names>Jéssica</given-names>
</name>
<xref ref-type="aff" rid="aff4"/>
</contrib>
<contrib contrib-type="author" corresp="no">
<name name-style="western">
<surname>Holanda</surname>
<given-names>Rose-Eloíse</given-names>
</name>
<xref ref-type="aff" rid="aff5"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution content-type="original">Sin institución</institution>
<country country="BR">Brasil</country>
<institution-wrap>
<institution content-type="orgname">Universidade Federal do Ceará</institution>
<institution-id institution-id-type="ror">https://ror.org/03srtnf24</institution-id>
</institution-wrap>
</aff>
<aff id="aff2">
<institution content-type="original">Sin institución</institution>
<country country="BR">Brasil</country>
<institution-wrap>
<institution content-type="orgname">Universidade Federal do Ceará</institution>
<institution-id institution-id-type="crossref">https://ror.org/03srtnf24</institution-id>
</institution-wrap>
</aff>
<aff id="aff3">
<institution content-type="original">Sin institución</institution>
<country country="BR">Brasil</country>
<institution-wrap>
<institution content-type="orgname">Universidade Federal do Ceará</institution>
<institution-id institution-id-type="ror">https://ror.org/03srtnf24</institution-id>
</institution-wrap>
</aff>
<aff id="aff4">
<institution content-type="original">Sin institución</institution>
<country country="BR">Brasil</country>
<institution-wrap>
<institution content-type="orgname">Universidade Federal do Ceará</institution>
<institution-id institution-id-type="ror">https://ror.org/03srtnf24</institution-id>
</institution-wrap>
</aff>
<aff id="aff5">
<institution content-type="original">Sin institución</institution>
<country country="BR">Brasil</country>
<institution-wrap>
<institution content-type="orgname">Faculdade Dom Adélio Tomasim</institution>
<institution-id institution-id-type="ror">https://ror.org/03srtnf24</institution-id>
</institution-wrap>
</aff>
<pub-date pub-type="epub-ppub">
<season>January-March</season>
<year>2025</year>
</pub-date>
<volume>15</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>6</lpage>
<history>
<date date-type="received" publication-format="dd mes yyyy">
<day>30</day>
<month>04</month>
<year>2024</year>
</date>
<date date-type="accepted" publication-format="dd mes yyyy">
<day>07</day>
<month>11</month>
<year>2024</year>
</date>
</history>
<permissions>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional.</license-p>
</license>
</permissions>
<abstract xml:lang="en">
<title>Abstract</title>
<p>
<bold>Background and Objectives:</bold> to assess nurses’ knowledge profile about the indications for the clinical management of <italic>influenza</italic>. <bold>Methods: </bold>descriptive cross-sectional study, carried out in October 2019. Sociodemographic and clinical variables were assessed of 53 nurses, compared using descriptive and univariate statistics. <bold>Results: </bold>nurses reported that returning to the health service to review the clinical condition is not an indication for the clinical management of patients with <italic>influenza</italic>-like syndrome (IS) with risk factors for complications (10; 19.0%). The indigenous population living in villages (3; 6.0%) and individuals under 19 years of age, in prolonged use of acetylsalicylic acid (36; 68.0%), are not/do not know that they are considered risk factors for complications. The use of symptomatic medications (5; 9.0%), the use of oseltamivir phosphate (16; 30.0%) and returning to the health service for review of the clinical condition (12; 23.0%) are not indications for the clinical management of patients with IS, without risk factors for complications, as well as the use of oxygen therapy, continuous monitoring and hospital admission if there are signs of worsening, including SatO2 &lt;95% (3; 6.0%), the use of oseltamivir phosphate (3; 6.0%), the performance of a radiological examination (1; 2.0%) and the control of hyperthermia with paracetamol (4; 7.0%) are not/do not know that they are indications for the clinical management of pregnant/postpartum women. <bold>Conclusion: </bold>nurses’ knowledge is satisfactory, but there are doubts regarding the care of more specific patients, such as pregnant and postpartum women as well as the risk factors or conditions for complications.</p>
</abstract>
<trans-abstract xml:lang="pt">
<title>Resumo</title>
<p>
<bold>Justificativa e Objetivos: </bold>avaliar o perfil de conhecimento de enfermeiros sobre as indicações para o manejo clínico da <italic>influenza</italic>. <bold>Métodos: </bold>estudo transversal descritivo, realizado em outubro de 2019. Foram avaliadas variáveis sociodemográficas e clínicas de 53 enfermeiros, comparadas através de estatística descritiva e univariada. <bold>Resultados</bold>: enfermeiros referiram que retornar ao serviço de saúde para revisão do quadro clínico não é uma indicação para o manejo clínico de pacientes com síndrome gripal (SG), com fatores de risco para complicações (10; 19,0%). População indígena aldeada (3; 6,0%) e indivíduos menores de 19 anos de idade, em uso prolongado de ácido acetilsalicílico (36; 68,0%), não são/não sabem que são considerados fatores de risco para complicações. O uso de medicamentos sintomáticos (5; 9,0%), o uso de fosfato de oseltamivir (16; 30,0%) e retornar ao serviço de saúde para revisão do quadro clínico (12; 23,0%) não são indicações para o manejo clínico do paciente com SG, sem fatores de risco para complicações, assim como o uso de oxigenoterapia, monitorização contínua e internação hospitalar se houver sinais de agravamento, incluindo SatO<sub>2</sub>&lt;95% (3; 6,0%), o uso de fosfato de oseltamivir (3; 6,0%), a realização de exame radiológico (1; 2,0%) e o controle de hipertermia com paracetamol (4; 7,0%) não são/não sabem que são indicações para o manejo clínico de gestantes/puérperas. <bold>Conclusão</bold>: o conhecimento dos enfermeiros é satisfatório, porém há dúvidas com relação ao cuidado de pacientes mais específicos, como grávidas e puérperas, bem como sobre os fatores ou condições de risco para complicações.</p>
</trans-abstract>
<trans-abstract xml:lang="es">
<title>Resumen</title>
<p>
<bold>Justificación y Objetivos</bold>: evaluar el perfil de conocimiento de los enfermeros sobre las indicaciones para el manejo clínico de la <italic>influenza</italic>. <bold>Métodos</bold>: estudio descriptivo transversal, realizado en octubre de 2019. Variables sociodemográficas y clínicas. Fueron evaluados 53 enfermeros, comparados mediante estadística descriptiva y univariada. <bold>Resultados: </bold>los enfermeros informaron que regresar al servicio de salud para revisar el cuadro clínico no es una indicación para el manejo clínico de pacientes con síndrome gripal (SG), con factores de riesgo para complicaciones (10; 19,0%). La población indígena de las aldeas (3; 6,0%) y los individuos menores de 19 años, en uso prolongado de ácido acetilsalicílico (36; 68,0%), no saben/no saben que se consideran factores de riesgo de complicaciones. El uso de medicamentos sintomáticos (5; 9,0%), el uso de fosfato de oseltamivir (16; 30,0%) y el regreso al servicio de salud para revisar el cuadro clínico (12; 23,0%) no son indicaciones para el manejo clínico de pacientes con SG, sin factores de riesgo de complicaciones, así como el uso de oxigenoterapia, monitorización continua e ingreso hospitalario si existen signos de empeoramiento, incluyendo SatO2&lt;95% (3; 6,0%), el uso de fosfato de oseltamivir (3; 6,0%), la realización de exámenes radiológicos (1; 2,0%) y el control de la hipertermia con paracetamol (4; 7,0%) no son/no saben que son indicaciones para el manejo clínico de mujeres embarazadas/posparto. <bold>Conclusión: </bold>el conocimiento de las enfermeras es satisfactorio, sin embargo, existen dudas respecto de la atención de pacientes más específicos, como las mujeres embarazadas y puérperas, así como los factores o condiciones de riesgo para complicaciones.</p>
</trans-abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>
<italic>Knowledge</italic>
</kwd>
<kwd>Human Influenza</kwd>
<kwd>Nurse</kwd>
</kwd-group>
<kwd-group xml:lang="pt">
<title>Palavras-chave</title>
<kwd>
<italic>Conhecimento</italic>
</kwd>
<kwd>Influenza Humana</kwd>
<kwd>Enfermeiro</kwd>
</kwd-group>
<kwd-group xml:lang="es">
<title>Palabras clave</title>
<kwd>
<italic>Conocimiento</italic>
</kwd>
<kwd>Gripe humana</kwd>
<kwd>Enfermero</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="25"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>redalyc-journal-id</meta-name>
<meta-value>5704</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec>
<title>
<bold>INTRODUCTION</bold>
</title>
<p>Respiratory diseases are the second leading cause of hospital admissions and the third leading cause of death worldwide, affecting 10% to 20% of the world’s population.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref1">1</xref>
</sup> Among them, <italic>influenza</italic> is present with its complications and evolution to severe forms, being considered, in the ranking, the first in number of hospital admissions, causing deaths and high costs to health services.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref2">2</xref>
</sup> And subtype A is responsible for the occurrence of most epidemics worldwide.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref3">3</xref>
</sup>
</p>
<p>
<italic>Influenza</italic> is an acute viral infectious disease of the respiratory system, which is highly transmissible and globally distributed, and has a self-limiting course. However, when severe forms manifest, it causes rapid and fatal death, especially in individuals who present risk factors or conditions for complications from the infection.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref3">3</xref>
</sup> The <italic>influenza</italic> virus, called <italic>Myxovirus influenzae</italic>, branches into types A, B and C, and only types A and B show clinical relevance in humans, being correlated with outbreaks and epidemics of respiratory origin.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref4">4</xref>
</sup>
</p>
<p>The most common complications of the <italic>influenza</italic> virus are <italic>influenza</italic>-like syndrome (IS), which consists of cases of people with fever, accompanied by cough and/or sore throat, with symptoms beginning in the last seven days, and severe acute respiratory syndrome (SARS), which is characterized by cases of people of any age, with IS, who present dyspnea or oxygen saturation (SpO<sub>2</sub>) &lt; 95%, in room air, signs of respiratory distress and increased respiratory rate, according to age, and hypotension, in relation to frequent blood pressure, before the onset of symptoms.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref3">3</xref>
</sup>
</p>
<p>Surveillance of <italic>influenza</italic> and other respiratory viruses in Brazil consists of sentinel surveillance of IS and surveillance of SARS in hospitalized patients and deaths from SARS. Its objective is to monitor cases of IS due to respiratory viruses of public health importance in selected health units, called sentinel units, so that they serve as an early warning to the surveillance system.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref5">5</xref>
</sup>
</p>
<p>Worldwide, it is estimated that one billion cases of <italic>influenza</italic> occur annually, with three to five million cases of severe illness, with mortality ranging from 290,000 to 650,000 due to complications related to the disease.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref6">6</xref>
</sup> In Brazil, in 2024, up to epidemiological week (EW) number 37, 61,124 cases of SARS were reported, with identification of respiratory viruses, 27% of which were <italic>influenza</italic> viruses, with 22% of deaths.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref7">7</xref>
</sup>In Ceará, up to EW 15 of 2024, it is shown that the <italic>influenza</italic> A virus was detected in 1,631 (46.8%) samples. Of these, 275 (16.9%) were subtyped, with a predominance of H1N1 in 172 (62.5%). A total of 2,268 cases of SARS were also confirmed in the state.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref8">8</xref>
</sup>
</p>
<p>At a national level, care for patients with <italic>influenza</italic> must currently be provided in accordance with the <italic>Influenza</italic> Management and Treatment Guide, which aims to guide therapeutic conduct for <italic>influenza</italic>, as well as intra- and extra-hospital control measures.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref5">5</xref>
</sup>
</p>
<p>Knowing and assessing nurses’ knowledge profile on the clinical management of patients with <italic>influenza</italic> will involve local, state and federal municipal managers, together with health professionals from each region of the country, to create ongoing and permanent educational strategies, through training on the use of <italic>influenza</italic> management and treatment guides, seeking to minimize errors resulting from unsafe care, as well as complications and injuries resulting from the disease. Thus, the study aims to assess nurses’ knowledge profile regarding the indications for the clinical management of <italic>influenza</italic>.</p>
</sec>
<sec>
<title>
<bold>METHODS</bold>
</title>
<p>This is a descriptive cross-sectional study carried out in Basic Health Units (BHU), Emergency Care Unit, polyclinic and municipal hospital, located in the municipality of Quixadá, in the state of Ceará, with approximately 80,600 inhabitants. The report was guided by the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref9">9</xref>
</sup>
</p>
<p>The study population consisted of 70 nurses, with the sample consisting of nurses working in the city’s health services. Nurses who had been working for more than three months in these locations were included. Nurses who were on maternity leave, vacation or away from work for some other reason during the data collection period were excluded, totaling 53 nurses.</p>
<p>The data were collected in October 2019, using a questionnaire-type instrument, prepared based on the Ministry of Health’s 2017 <italic>Influenza</italic> Treatment Protocol.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref10">10</xref>
</sup> The questionnaire has 11 items.</p>
<p>To collect data, daily visits were made to services, from Monday to Friday, approaching nurses, before or after their care activities, without interfering in care routine. At this time, the purpose of the study and its objective were presented to participants, explaining the importance of the Informed Consent Form. After a participant signed, the questionnaire was given to the participant to complete.</p>
<p>The data were tabulated in a spreadsheet created in Microsoft Excel by the researcher himself, based on the variables in the questionnaire. They were then subjected to statistical analysis using EPI INFO 7.0, generating percentage frequencies, which were displayed in tables and later interpreted and discussed in conjunction with the bibliography on the subject.</p>
<p>The research was designed in compliance with the ethical aspects recommended in Resolutions 466/12 and 518/2018 of the Brazilian National Health Council, which regulate research with human beings, and was approved under Opinion 3,660,758 and Certificate of Presentation for Ethical Consideration 23697019.7.0000.5046, on 10/24/2019.</p>
</sec>
<sec>
<title>
<bold>RESULTS </bold>
</title>
<p>The sociodemographic characterization of the 53 nurses participating in the research showed that the majority were women (49; 92.4%), aged between 31 and 59 years old (47; 88.8%), married/stable union (32; 60.0%), working at the BHU (18; 34.0%) (Table 1).</p>
<p>
<table-wrap id="gt1">
<label>Table 1</label>
<caption>
<title>Sociodemographic characterization of nurses in health services of Quixadá, Ceará. Quixadá, Ceará, Brazil, 2019</title>
</caption>
<alt-text>Table 1  Sociodemographic characterization of nurses in health services of Quixadá, Ceará. Quixadá, Ceará, Brazil, 2019</alt-text>
<alternatives>
<graphic xlink:href="570481700001_gt2.png" position="anchor" orientation="portrait"/>
<table style="border-collapse:collapse;" id="gt2-526564616c7963">
<thead style="display:none;">
<tr style="display:none;">
<th style="display:none;"/>
</tr>
</thead>
<tbody>
<tr style="height:13.9pt">
<td style="width:274.3pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;      padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>Variables</bold>
</td>
<td style="width:172.0pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;      padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>n=53(%)</bold>
</td>
</tr>
<tr style="height:13.9pt">
<td style="width:274.3pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>Sex</bold> Male Female</td>
<td style="width:172.0pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">     04 (7.6%) 49(92.4%)</td>
</tr>
<tr style="height:13.9pt">
<td style="width:274.3pt;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">
<bold>Age group</bold>18-30 years 31-59 years &gt;=60 years</td>
<td style="width:172.0pt;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">     05(9.4%) 47(88.8%) 01(1.8%)</td>
</tr>
<tr style="height:13.9pt">
<td style="width:274.3pt;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">
<bold>Marital status</bold> Single Married/stable union</td>
<td style="width:172.0pt;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">     21(40.0%) 32(60.0%)</td>
</tr>
<tr style="height:13.9pt">
<td style="width:274.3pt;border:none;border-bottom:   solid windowtext 1.0pt;   padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>Health service</bold>Basic Health UnitEmergency Care UnitPolyclinicMunicipal hospital  </td>
<td style="width:172.0pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt"> 18(34.0%) 16(30.0%) 03(6.0%) 16(30.0%)  </td>
</tr>
</tbody>
</table>
</alternatives>
<attrib>Source: research data (2019).</attrib>
</table-wrap>
</p>
<p>The analysis of the distribution of indications for the clinical management of patients with IS who present risk factors for complications revealed that all nurses demonstrated knowledge about the importance of the use of symptomatic medications, adequate hydration and oseltamivir phosphate, with 100% agreement on each of these measures (53; 100.0%). Furthermore, 81% of nurses (43) indicated the need to return to the health service to review patients’ clinical condition, while 19% (10) did not mention this recommendation (Table 2).</p>
<p>
<table-wrap id="gt2">
<label>Table 2</label>
<caption>
<title>Distribution of indications for clinical management of patients with influenza-like illness, with risk factors for complications, according to nurses’ knowledge. Quixadá, Ceará, Brazil, 2019</title>
</caption>
<alt-text>Table 2  Distribution of indications for clinical management of patients with influenza-like illness, with risk factors for complications, according to nurses’ knowledge. Quixadá, Ceará, Brazil, 2019</alt-text>
<alternatives>
<graphic xlink:href="570481700001_gt3.png" position="anchor" orientation="portrait"/>
<table style="border-collapse:collapse;border:none;  " id="gt3-526564616c7963">
<thead style="display:none;">
<tr style="display:none;">
<th style="display:none;"/>
</tr>
</thead>
<tbody>
<tr style="height:13.9pt">
<td style="width:297.7pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;      padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>Variables</bold>
</td>
<td style="width:61.0pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;      padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>n=53(%)</bold>
</td>
<td style="width:84.3pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;      padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt"/>
</tr>
<tr style="height:13.9pt">
<td style="width:297.7pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>Symptomatic medications</bold> Yes</td>
<td style="width:61.0pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">  53(100.0%)</td>
<td style="width:84.3pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt"/>
</tr>
<tr style="height:13.9pt">
<td style="width:297.7pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">
<bold>Hydration</bold> Yes No Does not know</td>
<td style="width:61.0pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">  53(100.0%)</td>
<td style="width:84.3pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt"/>
</tr>
<tr style="height:13.9pt">
<td style="width:297.7pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">
<bold>Oseltamivir phosphate</bold> Yes</td>
<td style="width:61.0pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">  53(100.0%)  </td>
<td style="width:84.3pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt"/>
</tr>
<tr style="height:13.9pt">
<td style="width:297.7pt;border:none;border-bottom:   solid windowtext 1.0pt;   padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>Returning to the health service to review the clinical condition</bold> Yes No  </td>
<td style="width:61.0pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">    43(81.0%) 10(19.0%)  </td>
<td style="width:84.3pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt"/>
</tr>
</tbody>
</table>
</alternatives>
<attrib>Source: research data (2019).</attrib>
</table-wrap>
</p>
<p>The distribution of conditions and risk factors for complications, according to nurses’ knowledge, indicated unanimous agreement (53;100%) in several categories, including pregnant women at any gestational age, postpartum women up to two weeks postpartum, adults aged 60 or over, children under five years old and individuals with conditions such as lung diseases, tuberculosis, cardiovascular diseases, nephropathies, liver diseases, hematological diseases, metabolic disorders, neurological disorders, immunosuppression, neoplasms, HIV/AIDS, among others, in addition to obesity.</p>
<p>A significant number of nurses (50;94%) also recognized the indigenous population living in villages or with difficult access as a risk group. However, a relevant portion (36;68%) is unaware that individuals under 19 years of age who are taking acetylsalicylic acid (ASA) for a long time are at risk of complications, which highlights an important gap in knowledge (Table 3).</p>
<p>
<table-wrap id="gt3">
<label>Table 3</label>
<caption>
<title>Distribution of condition(s) and risk factor(s) for influenza complications according to nurses’ knowledge. Quixadá, Ceará, Brazil, 2019</title>
</caption>
<alt-text>Table 3  Distribution of condition(s) and risk factor(s) for influenza complications according to nurses’ knowledge. Quixadá, Ceará, Brazil, 2019</alt-text>
<alternatives>
<graphic xlink:href="570481700001_gt4.png" position="anchor" orientation="portrait"/>
<table style="width:16.0cm;border-collapse:collapse;border:none;  " id="gt4-526564616c7963">
<thead style="display:none;">
<tr style="display:none;">
<th style="display:none;"/>
</tr>
</thead>
<tbody>
<tr style="height:13.9pt">
<td style="width:284.9pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;      padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>Variables</bold>
</td>
<td style="width:168.7pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;      padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>n=53(%)</bold>
</td>
</tr>
<tr style="height:13.9pt">
<td style="width:284.9pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>Pregnant women at any gestational age</bold>    Yes</td>
<td style="width:168.7pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">     53(100.0%)</td>
</tr>
<tr style="height:13.9pt">
<td style="width:284.9pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">
<bold>Women who have given birth up to two weeks after giving birth</bold>   Yes</td>
<td style="width:168.7pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">     53(100.0%)</td>
</tr>
<tr style="height:13.9pt">
<td style="width:284.9pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">
<bold>Adults    ≥             60           years</bold> Yes</td>
<td style="width:168.7pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">     53(100.0%)</td>
</tr>
<tr style="height:13.9pt">
<td style="width:284.9pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">
<bold>Children               &lt;              5             years</bold>   Yes</td>
<td style="width:168.7pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt"> 53(100.0%)</td>
</tr>
<tr style="height:13.9pt">
<td style="width:284.9pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">
<bold>Indigenous population living in villages or with difficult access               </bold>  Yes    Does not know</td>
<td style="width:168.7pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">         50(94.0%) 03(6.0%)</td>
</tr>
<tr style="height:13.9pt">
<td style="width:284.9pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">
<bold>Individuals under 19 years of age using acetylsalicylic acid for a long time</bold> Yes No    Does not know</td>
<td style="width:168.7pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">             11(21.0%) 36(68.0%) 06(11.0%)</td>
</tr>
<tr style="height:13.9pt">
<td style="width:284.9pt;border:none;border-bottom:   solid windowtext 1.0pt;   padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>Individuals with lung disease, tuberculosis of all forms, cardiovascular disease, nephropathy, liver disease, hematological diseases, metabolic disorders, neurological and developmental disorders that may compromise respiratory function or increase the risk of aspiration, immunosuppression associated with medications, neoplasms, HIV/AIDS or others, obesity</bold> Yes  </td>
<td style="width:168.7pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">                                         53(100.0%)  </td>
</tr>
</tbody>
</table>
</alternatives>
<attrib>Source: research data (2019).</attrib>
</table-wrap>
</p>
<p>In relation to the distribution of indications for clinical management of patients with IS, without risk factors for complications, the results were heterogeneous. All nurses reported the indication of hydration (53; 100.0%), while 48 (91.0%) mentioned the use of symptomatic medications, 36 (68.0%), the use of oseltamivir phosphate, and 41 (77.0%) advised returning to the health service to review the clinical condition (Table 4).</p>
<p>
<table-wrap id="gt4">
<label>Table 4</label>
<caption>
<title>Distribution of indications for clinical management of patients with influenza-like illness, without risk factors for complications, according to nurses’ knowledge. Quixadá, Ceará, Brazil, 2019</title>
</caption>
<alt-text>Table 4  Distribution of indications for clinical management of patients with influenza-like illness, without risk factors for complications, according to nurses’ knowledge. Quixadá, Ceará, Brazil, 2019</alt-text>
<alternatives>
<graphic xlink:href="570481700001_gt5.png" position="anchor" orientation="portrait"/>
<table style="width:16.0cm;border-collapse:collapse;" id="gt5-526564616c7963">
<thead style="display:none;">
<tr style="display:none;">
<th style="display:none;"/>
</tr>
</thead>
<tbody>
<tr style="height:10.5pt">
<td style="width:11.0cm;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;      padding:0cm 5.4pt 0cm 5.4pt;height:10.5pt">
<bold>Variables</bold>
</td>
<td style="width:5.0cm;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;      padding:0cm 5.4pt 0cm 5.4pt;height:10.5pt">
<bold>        n=53(%)</bold>
</td>
</tr>
<tr style="height:32.2pt">
<td style="width:11.0cm;border:none;padding:0cm 5.4pt 0cm 5.4pt;height:32.2pt">
<bold>Symptomatic medications</bold> Yes No</td>
<td style="width:5.0cm;border:none;padding:0cm 5.4pt 0cm 5.4pt;height:32.2pt">     48(91.0%) 05(9.0%)</td>
</tr>
<tr style="height:21.0pt">
<td style="width:11.0cm;padding:0cm 5.4pt 0cm 5.4pt;   height:21.0pt">
<bold>Hydration</bold> Yes</td>
<td style="width:5.0cm;padding:0cm 5.4pt 0cm 5.4pt;   height:21.0pt">     53(100.0%)</td>
</tr>
<tr style="height:70.45pt">
<td style="width:11.0cm;padding:0cm 5.4pt 0cm 5.4pt;   height:70.45pt">
<bold>Oseltamivir phosphate</bold> Yes No    Does not know  </td>
<td style="width:5.0cm;padding:0cm 5.4pt 0cm 5.4pt;   height:70.45pt"> 36(68.0%)16(30.0%)01(2.0%)</td>
</tr>
<tr style="height:53.2pt">
<td style="width:11.0cm;border:none;border-bottom:   solid windowtext 1.0pt;   padding:0cm 5.4pt 0cm 5.4pt;height:53.2pt">
<bold>Returning to the health service to review the clinical condition</bold> Yes No  </td>
<td style="width:5.0cm;border:none;border-bottom:solid windowtext 1.0pt;   padding:0cm 5.4pt 0cm 5.4pt;   height:53.2pt">         41(77.0%) 12(23.0%)  </td>
</tr>
</tbody>
</table>
</alternatives>
<attrib>Source: research data (2019).</attrib>
</table-wrap>
</p>
<p>The distribution of indications for the clinical management of pregnant and postpartum women, according to nurses’ knowledge, identified that all refer to: complete physical examination with measurement of vital signs (53; 100.0%); observing warning signs in pregnant women with respiratory rate values &gt;20 rpm or heart rate &gt;100 bpm% (53; 100.0%); and precautions with newborns in the postpartum period (53; 100.0%) (Table 5).</p>
<p>
<table-wrap id="gt5">
<label>Table 5</label>
<caption>
<title>Distribution of indications for clinical management of pregnant and postpartum women according to nurses’ knowledge. Quixadá, Ceará, Brazil, 2019</title>
</caption>
<alt-text>Table 5  Distribution of indications for clinical management of pregnant and postpartum women according to nurses’ knowledge. Quixadá, Ceará, Brazil, 2019</alt-text>
<alternatives>
<graphic xlink:href="570481700001_gt6.png" position="anchor" orientation="portrait"/>
<table style="border-collapse:collapse;border:none;  " id="gt6-526564616c7963">
<thead style="display:none;">
<tr style="display:none;">
<th style="display:none;"/>
</tr>
</thead>
<tbody>
<tr style="height:13.9pt">
<td style="width:290.6pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;      padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>Variables</bold>
</td>
<td style="width:155.95pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;      padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>n=53(%)</bold>
</td>
</tr>
<tr style="height:13.9pt">
<td style="width:290.6pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>Complete physical examination with measurement of vital signs</bold>  Yes  </td>
<td style="width:155.95pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">     53(100%)  </td>
</tr>
<tr style="height:13.9pt">
<td style="width:290.6pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">
<bold>Observing warning signs in pregnant women with respiratory rate values &gt;20 rpm or heart rate &gt;100 bpm%</bold>  Yes  </td>
<td style="width:155.95pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">             53(100%)  </td>
</tr>
<tr style="height:13.9pt">
<td style="width:290.6pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">
<bold>Oxygen therapy, continuous monitoring and hospital admission if there are signs of worsening, including SatO<sub>2</sub>&lt;95%</bold>    Yes No  </td>
<td style="width:155.95pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">             50(94.0%) 03(6.0%)  </td>
</tr>
<tr style="height:13.9pt">
<td style="width:290.6pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">
<bold>Oseltamivir phosphate </bold>    Yes No    Does not know  </td>
<td style="width:155.95pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">     49(92.0%) 01(2.0%) 03(6.0%)  </td>
</tr>
<tr style="height:13.9pt">
<td style="width:290.6pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">
<bold>Radiological examination</bold>    Yes No  </td>
<td style="width:155.95pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">         52(98.0%) 01(2.0%)  </td>
</tr>
<tr style="height:13.9pt">
<td style="width:290.6pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">
<bold>Controlling hyperthermia with paracetamol</bold>    Yes No    Does not know  </td>
<td style="width:155.95pt;border:none;padding:0cm 5.4pt 0cm 5.4pt;   height:13.9pt">     47(89.0%) 04(7.0%) 02(4.0%)  </td>
</tr>
<tr style="height:13.9pt">
<td style="width:290.6pt;border:none;border-bottom:   solid windowtext 1.0pt;   padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">
<bold>Precautions for newborns in the postpartum period</bold>   Yes  </td>
<td style="width:155.95pt;border:none;border-bottom:   solid windowtext 1.0pt;   padding:0cm 5.4pt 0cm 5.4pt;height:13.9pt">             53(100.0%)  </td>
</tr>
</tbody>
</table>
</alternatives>
<attrib>Source: research data (2019).</attrib>
</table-wrap>
</p>
<p>All nurses are aware of the indications for clinical management of patients with SARS, such as: hospital admission; intravenous hydration; oxygen therapy; maintaining clinical monitoring; measuring vital signs; oseltamivir phosphate; collecting respiratory secretion samples for laboratory testing; and indications for hospitalization of patients with <italic>influenza</italic> in the Intensive Care Unit (ICU), such as: persistent hemodynamic instability; signs and symptoms of respiratory failure, including hypoxemia requiring oxygen supplementation to maintain arterial oxygen saturation above 90%; and progression to other organ dysfunctions, such as acute renal failure and neurological dysfunction.</p>
<p>As for the problems and failures in implementing clinical management based on the 2017 <italic>Influenza</italic> Treatment Protocol, all reported a lack of training on the use of the protocol (53; 100.0%), and more than 50% reported a lack of knowledge about the disease (34; 64.0%), lack of knowledge about the protocol (37; 70.0%) and lack of training by the municipality (45; 85.0%).</p>
</sec>
<sec>
<title>
<bold>DISCUSSION</bold>
</title>
<p>The study describes the knowledge of 53 nurses about the indications for the clinical management of patients with <italic>influenza</italic>, a seasonal infection that causes significant morbidity and mortality and economic losses, worldwide and every year, requiring targeted and quality care for patients at different levels of care.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref11">11</xref>
</sup>
</p>
<p>Regarding the disease clinical management, it is known that all patients with IS and with conditions and risk factors for complications should be advised to return to the health service for a review of clinical condition, where they should be reassessed in relation to the criteria for SARS or other signs of worsening. It can be seen, therefore, that the professionals investigated had good knowledge regarding many care measures; in this item, however, the health team needs to know that the importance of returning to the health service to reassess the health status is an essential step in the clinical management of the disease of patients with IS and risk factors for complications. <sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref5">5</xref>
</sup>
</p>
<p>The study showed that, in the sample analyzed, there are nurses who are unaware that indigenous populations living in villages or with difficult access constitute one of the risk factors for complications from <italic>influenza</italic>. However, Ordinance 2,436 of September 21, 2017, which approves the Brazilian National Primary Care Policy, considers that it is a common responsibility of all members of teams working in Primary Health Care, such as nurses, to be responsible for monitoring the population involved, meeting the needs for preventive care and seeking comprehensiveness in the provision of services.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref12">12</xref>-<xref ref-type="bibr" rid="redalyc_570481700001_ref13">13</xref>
</sup>
</p>
<p>Another variable that deserves attention, as it presented a result that differs from what is recommended in the literature, is that individuals under 19 years of age, in prolonged use of ASA, is also not a risk factor for complications from <italic>influenza</italic>. In this context, it is worth mentioning that, since 1980, the Food and Drug Administration and the Centers for Disease Control and Prevention recommend that aspirin should not be used to treat acute febrile viral illnesses in children and adolescents under 19 years of age, as its use may cause Reye’s syndrome, which is a rare but life-threatening acute non-inflammatory encephalopathy with fatty liver failure.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref14">14</xref>-<xref ref-type="bibr" rid="redalyc_570481700001_ref15">15</xref>
</sup>
</p>
<p>Regarding the indications for clinical management of patients with IS without risk factors for complications, a significant percentage of nurses report that the use of oseltamivir phosphate is not recommended. It is known that oseltamivir phosphate has extensive evidence supporting its safe and effective use in the treatment and prevention of <italic>influenza</italic> in older adults, including those with complicated infections or who reside in Nursing Homes, requiring only dose adjustments in renal patients.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref16">16</xref>
</sup>Furthermore, its prescription, in addition to symptomatic medications and hydration, should be considered based on clinical judgment, preferably in the first 48 hours after the onset of the disease.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref5">5</xref>
</sup>
</p>
<p>During pregnancy, extending into the puerperal phase, physiological changes occur, including changes in cellular immunity, increased heart rate and systolic volume, and increased oxygen consumption, which leads to cautious care by nurses when pregnant and postpartum women are affected by <italic>influenza</italic>. It is a cause for concern that, in this study, some nurses reported not knowing important indications when approaching this population.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref17">17</xref>-<xref ref-type="bibr" rid="redalyc_570481700001_ref18">18</xref>
</sup>However, ideally, these professionals, in their services, should promote efforts to improve vaccination coverage, through informative conversations with patients, which could protect mothers and their babies against serious respiratory diseases.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref19">19</xref>
</sup>
</p>
<p>Regarding the care of patients with <italic>influenza</italic> that progress to SARS, characterized by symptoms of high fever, cough and dyspnea, accompanied by increased respiratory rate, hypotension in relation to patients’ usual blood pressure, and, often, lack of smell, taste and appetite, it is known that the recognition of these signs of severity by nurses is essential, in order to carry out the appropriate indications in the clinical management of these patients, as seen in the results of this research, as this is one of the most worrying manifestations among respiratory infections in humans.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref5">5</xref>, <xref ref-type="bibr" rid="redalyc_570481700001_ref20">20</xref>
</sup>
</p>
<p>Turning to indications for patients with <italic>influenza</italic> who should be admitted to the ICU, research, which sought to analyze a large cohort of patients hospitalized, in this context, for severe <italic>influenza</italic>, over ten years, showed that overall mortality was 25.1%. The predominant clinical presentation was specific lung involvement, which rapidly required mechanical ventilation and often progressed to acute respiratory distress syndrome. Therefore, timely admission to the ICU is recommended as early as possible in cases of respiratory failure in order to allow effective intensive care, which was known to all nurses working in the health services studied.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref21">21</xref>
</sup>
</p>
<p>Finally, regarding the problems and failures in implementing clinical management based on the 2017 <italic>Influenza</italic> Treatment Protocol, alarming data were found in the research regarding nurses’ lack of knowledge about <italic>influenza</italic> and the protocol for managing it clinically, as well as the result of a study that sought to understand the dynamics of knowledge, attitudes and practices of health professionals related to <italic>influenza</italic>, suggesting political implications and advocating the review of national strategies to strengthen the training of health professionals on a disease that has been present in Brazil since the last century, and which has a large increase in the number of cases each year.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref22">22</xref>
</sup>
</p>
<p>Furthermore, the report of the municipality’s lack of training on the disease and the use of the treatment protocol is quite concerning, considering that <italic>influenza</italic> continues to cause up to five million cases of serious illness resulting in 500,000 deaths worldwide.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref23">23</xref>
</sup> However, in Brazil, the Brazilian National Policy for Continuing Education seeks to transform health work, with the aim of encouraging critical, reflective, committed and technically efficient action, and respect for regional characteristics and specific training needs of professionals working in health services, for the transformation of health practices towards meeting the fundamental principles of the Brazilian Health System, based on local reality and collective analysis of work processes. It is clear that it is the role of health managers and professionals to seek to improve health practices to the detriment of offering quality care.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref24">24</xref>
</sup>
</p>
<p>Finally, each year, changes in the viral involvement profile of different types of diseases may reflect the effect of different variants, which implies the relevance of knowledge by nurses as well as by all health professionals about the clinical management not only of <italic>influenza</italic>, but of several other viral infections, based on the recommendations of official guidelines and protocols of national and international government agencies, in order to offer safe care to patients.<sup>
<xref ref-type="bibr" rid="redalyc_570481700001_ref25">25</xref>
</sup>
</p>
<p>The study’s limitations included the lack of availability and lack of interest of most professionals in answering the questionnaire, as many reported not feeling confident enough to answer, mainly due to a lack of knowledge about the protocol and even about the disease. Many nurses also stated that there were no cases of <italic>influenza</italic> in their services.</p>
<p>In conclusion, the study achieved its objective by assessing nurses’ knowledge profile regarding the indications for clinical management of <italic>influenza</italic>. The results demonstrate that, although nurses have a good level of knowledge in most of the areas assessed, some important gaps were identified.</p>
<p>It is suggested that municipal health departments carry out more frequent training in relation to the entire context surrounding the disease, since it is a pathology that affects people worldwide every year.<bold/>
</p>
</sec>
</body>
<back>
<ref-list>
<title>
<bold>REFERENCES</bold>
</title>
<ref id="redalyc_570481700001_ref1">
<mixed-citation publication-type="journal">1. Espinoza CA, Peralta CL. Characterization of pre- and post-vaccination immunity with influenza in patients with human immunodeficiency virus. Collegiate Journal of Science 2018; 3(1): 30-45. <ext-link ext-link-type="uri" xlink:href="http://portal.amelica.org/ameli/journal/334/3342538006/3342538006.pdf">http://portal.amelica.org/ameli/journal/334/3342538006/3342538006.pdf</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Espinoza</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Peralta</surname>
<given-names>CL</given-names>
</name>
</person-group>
<article-title>Characterization of pre- and post-vaccination immunity with influenza in patients with human immunodeficiency virus.</article-title>
<source>Collegiate Journal of Science</source>
<year>2018</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="http://portal.amelica.org/ameli/journal/334/3342538006/3342538006.pdf">http://portal.amelica.org/ameli/journal/334/3342538006/3342538006.pdf</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref2">
<mixed-citation publication-type="journal">2. Aoyama EA, Nunes ECA, Oliveira MS, et al. Os benefícios da vacina H1N1 em idosos. Brazilian Journal of health. 2019; 2(1):185-191. <ext-link ext-link-type="uri" xlink:href="https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/880/762">https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/880/762</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aoyama</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Nunes</surname>
<given-names>ECA</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Os benefícios da vacina H1N1 em idosos.</article-title>
<source>Brazilian Journal of health</source>
<year>2019</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/880/762">https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/880/762</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref3">
<mixed-citation publication-type="book">3. BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Departamento de Articulação Estratégica de Vigilância em Saúde e Ambiente. Guia de vigilância em saúde: volume 3. 6.ed. Brasília: Ministério da Saúde; 2023. <ext-link ext-link-type="uri" xlink:href="https://bvsms.saude.gov.br/bvs/publicacoes/guia_vigilancia_saude_6ed_v3.pdf">https://bvsms.saude.gov.br/bvs/publicacoes/guia_vigilancia_saude_6ed_v3.pdf</ext-link>
</mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>BRASIL</collab>
</person-group>
<source>Guia de vigilância em saúde: volume 3.</source>
<year>2023</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://bvsms.saude.gov.br/bvs/publicacoes/guia_vigilancia_saude_6ed_v3.pdf">https://bvsms.saude.gov.br/bvs/publicacoes/guia_vigilancia_saude_6ed_v3.pdf</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref4">
<mixed-citation publication-type="book">4. Molin RSD. Saúde em Foco: Doenças Emergentes e Remergentes. In: Ribeiro JF, Bellei NCJ, Chaves NSG et al. Influenza (Gripe1). 1 ed. Brasil: Editora Científica Digital; 2020. p.2-31. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.37885/201001751">https://doi.org/10.37885/201001751</ext-link>
</mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Molin</surname>
<given-names>RSD</given-names>
</name>
</person-group>
<source>Influenza (Gripe1).</source>
<year>2020</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.37885/201001751">https://doi.org/10.37885/201001751</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref5">
<mixed-citation publication-type="book">5. BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Departamento do Programa Nacional de Imunizações e Doenças Imunopreviníveis. Guia de Manejo e Tratamento de Influenza 2023. Brasília: Ministério da Saúde; 2023.</mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>BRASIL</collab>
</person-group>
<source>Guia de Manejo e Tratamento de Influenza 2023</source>
<year>2023</year>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref6">
<mixed-citation publication-type="webpage">6. World Health Organization. WHO and World Health Organization: WHO, “Influenza (Seasonal)”; 2023. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal">https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal</ext-link>)</mixed-citation>
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>
<source>WHO and World Health Organization: WHO, “Influenza (Seasonal)”</source>
<year>2023</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal">https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref7">
<mixed-citation publication-type="webpage">7. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Informe Vigilância das Síndromes Gripais. Influenza, Covid-19 e outros vírus respiratórios de importância em saúde pública. Semana epidemiológica 2. 26 de setembro de 2024. <ext-link ext-link-type="uri" xlink:href="https://www.gov.br/saude/pt-br/assuntos/covid-19/atualizacao-de-casos/informe-se-37-de-2024.pdf/view">https://www.gov.br/saude/pt-br/assuntos/covid-19/atualizacao-de-casos/informe-se-37-de-2024.pdf/view</ext-link>
</mixed-citation>
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>Brasil</collab>
</person-group>
<source>Influenza, Covid-19 e outros vírus respiratórios de importância em saúde pública.</source>
<year>2024</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://www.gov.br/saude/pt-br/assuntos/covid-19/atualizacao-de-casos/informe-se-37-de-2024.pdf/view">https://www.gov.br/saude/pt-br/assuntos/covid-19/atualizacao-de-casos/informe-se-37-de-2024.pdf/view</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref8">
<mixed-citation publication-type="webpage">8. Ceará. Governo do Estado. Informe operacional Cenário epidemiológico dos vírus respiratórios. Nº 03. Atualização em: 26/09/2024. <ext-link ext-link-type="uri" xlink:href="https://www.saude.ce.gov.br/wp-content/uploads/sites/9/2020/02/INFORME-No3-Cenario-epidemiologico-dos-virus-respiratorios-2024.pdf">https://www.saude.ce.gov.br/wp-content/uploads/sites/9/2020/02/INFORME-No3-Cenario-epidemiologico-dos-virus-respiratorios-2024.pdf</ext-link>
</mixed-citation>
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>Ceará</collab>
</person-group>
<source>Informe operacional Cenário epidemiológico dos vírus respiratórios.</source>
<year>2024</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://www.saude.ce.gov.br/wp-content/uploads/sites/9/2020/02/INFORME-No3-Cenario-epidemiologico-dos-virus-respiratorios-2024.pdf">https://www.saude.ce.gov.br/wp-content/uploads/sites/9/2020/02/INFORME-No3-Cenario-epidemiologico-dos-virus-respiratorios-2024.pdf</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref9">
<mixed-citation publication-type="journal">9. Malta M, Cardoso LO, Bastos FI, et al. Iniciativa STROBE: subsídios para a comunicação de estudos observacionais. Rev Saude Publica. 2010; 44(3):559-65. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/S0034-89102010000300021">https://doi.org/10.1590/S0034-89102010000300021</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malta</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cardoso</surname>
<given-names>LO</given-names>
</name>
<name>
<surname>Bastos</surname>
<given-names>FI</given-names>
</name>
</person-group>
<article-title>Iniciativa STROBE: subsídios para a comunicação de estudos observacionais.</article-title>
<source>Rev Saude Publica.</source>
<year>2010</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/S0034-89102010000300021">https://doi.org/10.1590/S0034-89102010000300021</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref10">
<mixed-citation publication-type="webpage">10. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Protocolo de Tratamento de Influenza. Brasília; 2017. <ext-link ext-link-type="uri" xlink:href="https://bvsms.saude.gov.br/bvs/publicacoes/protocolo_tratamento_influenza_2017.pdf">https://bvsms.saude.gov.br/bvs/publicacoes/protocolo_tratamento_influenza_2017.pdf</ext-link>
</mixed-citation>
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>Brasil</collab>
</person-group>
<source>Protocolo de Tratamento de Influenza.</source>
<year>2017</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://bvsms.saude.gov.br/bvs/publicacoes/protocolo_tratamento_influenza_2017.pdf">https://bvsms.saude.gov.br/bvs/publicacoes/protocolo_tratamento_influenza_2017.pdf</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref11">
<mixed-citation publication-type="journal">11. Moreno M, Pérez-Martín J, Mañueco MR. Parents and teachers’ perspectives on a school-located influenza vaccination program: A pilot study in the Region of Murcia, Spain. Human Vaccines &amp; Immunotherapeutics. 2024; 20(1):1-8. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/21645515.2024.2328406">https://doi.org/10.1080/21645515.2024.2328406</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreno</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pérez-Martín</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mañueco</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>Parents and teachers’ perspectives on a school-located influenza vaccination program: A pilot study in the Region of Murcia, Spain.</article-title>
<source>Human Vaccines &amp; Immunotherapeutics</source>
<year>2024</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/21645515.2024.2328406">https://doi.org/10.1080/21645515.2024.2328406</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref12">
<mixed-citation publication-type="legal-doc">12. Brasil. Ministério da Saúde. Política Nacional de Atenção Básica - Portaria no 2.436, de 21 de setembro de 2017. Brasília: MS; 2017. Disponível em: <ext-link ext-link-type="uri" xlink:href="http://bvsms.saude.gov.br/bvs/saudelegis/gm/2017/prt2436_22_09_2017.html">http://bvsms.saude.gov.br/bvs/saudelegis/gm/2017/prt2436_22_09_2017.html</ext-link>
</mixed-citation>
<element-citation publication-type="legal-doc">
<person-group person-group-type="author">
<collab>Brasil</collab>
</person-group>
<source>Portaria no 2.436, de 21 de setembro de 2017</source>
<year>2017</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="http://bvsms.saude.gov.br/bvs/saudelegis/gm/2017/prt2436_22_09_2017.html">http://bvsms.saude.gov.br/bvs/saudelegis/gm/2017/prt2436_22_09_2017.html</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref13">
<mixed-citation publication-type="journal">13. Holanda WTG, Oliveira SB, Sanchez MN. Differential aspects in the access to and quality of primary health care within the scope of the vaccine coverage for influenza. Ciência &amp; Saúde Coletiva. 2022; 27(4): 1679-94. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/1413-81232022274.03472021">https://doi.org/10.1590/1413-81232022274.03472021</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holanda</surname>
<given-names>WTG</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Sanchez</surname>
<given-names>MN</given-names>
</name>
</person-group>
<article-title>Differential aspects in the access to and quality of primary health care within the scope of the vaccine coverage for influenza.</article-title>
<source>Ciência &amp; Saúde Coletiva</source>
<year>2022</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1590/1413-81232022274.03472021">https://doi.org/10.1590/1413-81232022274.03472021</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref14">
<mixed-citation publication-type="journal">14. Di Bella S, Luzzati R, Principe L, et al. Aspirin and infection: A narrative review. Biomedicines 2022; 10(2): 263. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/biomedicines10020263">https://doi.org/10.3390/biomedicines10020263</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>S</surname>
<given-names>Di Bella</given-names>
</name>
<name>
<surname>Luzzati</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Principe</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Aspirin and infection: A narrative review.</article-title>
<source>Biomedicines</source>
<year>2022</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/biomedicines10020263">https://doi.org/10.3390/biomedicines10020263</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref15">
<mixed-citation publication-type="book">15. Chapman J, Arnold JK. Reye syndrome. In StatPearls. StatPearls Publishing: Treasure Island; 2023. <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK526101">https://www.ncbi.nlm.nih.gov/books/NBK526101</ext-link>/</mixed-citation>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Chapman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>JK</given-names>
</name>
</person-group>
<source>Reye syndrome.</source>
<year>2023</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK526101">https://www.ncbi.nlm.nih.gov/books/NBK526101</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref16">
<mixed-citation publication-type="journal">16. Abd El, Hadi H. Mini analytical review of different techniques applied for oseltamivir phosphate estimation in various matrices. ERU Research Journal. 2024; 3(1): 837-848. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.21608/erurj.2024.337762">https://doi.org/10.21608/erurj.2024.337762</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hadi</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Mini analytical review of different techniques applied for oseltamivir phosphate estimation in various matrices.</article-title>
<source>ERU Research Journal.</source>
<year>2024</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.21608/erurj.2024.337762">https://doi.org/10.21608/erurj.2024.337762</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref17">
<mixed-citation publication-type="journal">17. Bernardi BA, Marcolin P, Lindemann IL, et al. Prevalência de Influenza A, vírus sincicial respiratório e SARS-COV-2 em pacientes com síndrome respiratória aguda grave em Passo Fundo - RS. Semin. Cienc. Biol. Saude. 2023; 44(2):113-26. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5433/1679-0367.2023v44n2p113">https://doi.org/10.5433/1679-0367.2023v44n2p113</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernardi</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Marcolin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lindemann</surname>
<given-names>IL</given-names>
</name>
</person-group>
<article-title>Prevalência de Influenza A, vírus sincicial respiratório e SARS-COV-2 em pacientes com síndrome respiratória aguda grave em Passo Fundo - RS.</article-title>
<source>Semin. Cienc. Biol. Saude.</source>
<year>2023</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5433/1679-0367.2023v44n2p113">https://doi.org/10.5433/1679-0367.2023v44n2p113</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref18">
<mixed-citation publication-type="journal">18. Blanchard-Rohner G, Eberhardt C. Review of maternal immunisation during pregnancy: focus on pertussis and influenza. Swiss Med Wkly. 2017; 147(4344):w14526. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4414/smw.2017.14526">https://doi.org/10.4414/smw.2017.14526</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blanchard-Rohner</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Eberhardt</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Review of maternal immunisation during pregnancy: focus on pertussis and influenza.</article-title>
<source>Swiss Med Wkly.</source>
<year>2017</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4414/smw.2017.14526">https://doi.org/10.4414/smw.2017.14526</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref19">
<mixed-citation publication-type="journal">19. Bulloch MN. Treatment and prevention of influenza in geriatric patients. Expert Review of Clinical Pharmacology. 2023; 16(9), 825–841. <ext-link ext-link-type="uri" xlink:href="https://doi-org.ez11.periodicos.capes.gov.br/10.1080/17512433.2023.2243221">https://doi-org.ez11.periodicos.capes.gov.br/10.1080/17512433.2023.2243221</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bulloch</surname>
<given-names>MN</given-names>
</name>
</person-group>
<article-title>Treatment and prevention of influenza in geriatric patients.</article-title>
<source>Expert Review of Clinical Pharmacology.</source>
<year>2023</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi-org.ez11.periodicos.capes.gov.br/10.1080/17512433.2023.2243221">https://doi-org.ez11.periodicos.capes.gov.br/10.1080/17512433.2023.2243221</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref20">
<mixed-citation publication-type="journal">20. Grohskopf LA, Alyanak E, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2019–20 influenza season. MMWR Recomm Rep. 2019; 68(3): 1-21. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.15585/mmwr.rr6803a1">http://dx.doi.org/10.15585/mmwr.rr6803a1</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grohskopf</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Alyanak</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Broder</surname>
<given-names>KR</given-names>
</name>
</person-group>
<article-title>Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2019–20 influenza season.</article-title>
<source>MMWR Recomm Rep.</source>
<year>2019</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.15585/mmwr.rr6803a1">http://dx.doi.org/10.15585/mmwr.rr6803a1</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref21">
<mixed-citation publication-type="journal">21. Razzaghi H, Kahn KE, Calhoun K, et al. Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy Among Pregnant Women — United States, April 2023. MMWR Morb Mortal Wkly Rep. 2023; 72:1065 - 1071. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.15585/mmwr.mm7239a4">http://dx.doi.org/10.15585/mmwr.mm7239a4</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Razzaghi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Calhoun</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy Among Pregnant Women — United States, April 2023.</article-title>
<source>MMWR Morb Mortal Wkly Rep.</source>
<year>2023</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.15585/mmwr.mm7239a4">http://dx.doi.org/10.15585/mmwr.mm7239a4</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref22">
<mixed-citation publication-type="journal">22. Akmatova R, Ebama MS, Temirbekov S, et al. A comparative analysis of knowledge, attitude, and practice (KAP) towards influenza and influenza vaccination among healthcare workers in Kyrgyzstan prior to and during the COVID-19 pandemic. Vaccines. 2024. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2024.04.008">https://doi.org/10.1016/j.vaccine.2024.04.008</ext-link>.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akmatova</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ebama</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Temirbekov</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>A comparative analysis of knowledge, attitude, and practice (KAP) towards influenza and influenza vaccination among healthcare workers in Kyrgyzstan prior to and during the COVID-19 pandemic.</article-title>
<source>Vaccines</source>
<year>2024</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2024.04.008">https://doi.org/10.1016/j.vaccine.2024.04.008</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref23">
<mixed-citation publication-type="journal">23. Betancourt-Cravioto M, Falcón-Lezama JA, Saucedo-Martínez R, et al. Public health and economic benefits of influenza vaccination of the population aged 50 to 59 years without risk factors for influenza complications in Mexico: a cross-sectional epidemiological study. Vaccines. 2021; 9(3):188. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/vaccines9030188">https://doi.org/10.3390/vaccines9030188</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betancourt-Cravioto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Falcón-Lezama</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Saucedo-Martínez</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Public health and economic benefits of influenza vaccination of the population aged 50 to 59 years without risk factors for influenza complications in Mexico: a cross-sectional epidemiological study.</article-title>
<source>Vaccines</source>
<year>2021</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/vaccines9030188">https://doi.org/10.3390/vaccines9030188</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref24">
<mixed-citation publication-type="webpage">24. Brasil. Ministério da Saúde. Política Nacional de Educação Permanente em Saúde: o que se tem produzido para o seu fortalecimento? Brasília: Ministério da Saúde; 2018. <ext-link ext-link-type="uri" xlink:href="https://conselho.saude.gov.br/images/publicacoes2023/politica_nacional_educacao_permanente_saude_fortalecimento.pdf">https://conselho.saude.gov.br/images/publicacoes2023/politica_nacional_educacao_permanente_saude_fortalecimento.pdf</ext-link>
</mixed-citation>
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>Brasil</collab>
</person-group>
<source>Política Nacional de Educação Permanente em Saúde: o que se tem produzido para o seu fortalecimento?</source>
<year>2018</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://conselho.saude.gov.br/images/publicacoes2023/politica_nacional_educacao_permanente_saude_fortalecimento.pdf">https://conselho.saude.gov.br/images/publicacoes2023/politica_nacional_educacao_permanente_saude_fortalecimento.pdf</ext-link>
</comment>
</element-citation>
</ref>
<ref id="redalyc_570481700001_ref25">
<mixed-citation publication-type="journal">25. Beck JL, Renner JDP, Carneiro M, et al. Aspectos clínicos e sociodemográficos dos casos de Síndrome Respiratória Aguda Grave no sul do Brasil. Rev Epidemiol Control Infect. 2023; 13(3):1-14. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17058/reci.v13i3.17903">https://doi.org/10.17058/reci.v13i3.17903</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beck</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Renner</surname>
<given-names>JDP</given-names>
</name>
<name>
<surname>Carneiro</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Aspectos clínicos e sociodemográficos dos casos de Síndrome Respiratória Aguda Grave no sul do Brasil.</article-title>
<source>Rev Epidemiol Control Infect.</source>
<year>2023</year>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17058/reci.v13i3.17903">https://doi.org/10.17058/reci.v13i3.17903</ext-link>
</comment>
</element-citation>
</ref>
</ref-list>
</back>
</article>